These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2866620)

  • 1. Biological control to diminish dangers of urolithiasis.
    Sarig S; Azoury R; Garti N
    Urol Int; 1985; 40(5):274-6. PubMed ID: 2866620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. May enzyme activity in urine play a role in kidney stone formation?
    Azoury R; Garti N; Perlberg S; Sarig S
    Urol Res; 1982; 10(4):185-9. PubMed ID: 6129728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observations on calcium oxalate stone formers.
    el-Sharabasy MM
    Br J Urol; 1992 Nov; 70(5):474-7. PubMed ID: 1361403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of GOT activity on nucleation and crystal growth of calcium oxalate.
    Azoury R; Sarig S; Garti N; Perlberg S; Randolph AD; Drach GW
    Urol Res; 1984; 12(4):223-6. PubMed ID: 6149642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retardation of calcium oxalate precipitation by glutamic-oxalacetic-transaminase activity.
    Azoury R; Sarig S; Garti N; Perlberg S
    Urol Res; 1982; 10(4):169-72. PubMed ID: 7179608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
    Laube N; Jansen B; Hesse A
    Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of glutamic acid and aspartic acid on calcium oxalate crystal formation.
    Kohri K; Umekawa T; Kodama M; Katayama Y; Ishikawa Y; Takada M; Katoh Y; Kataoka K; Iguchi M; Kurita T
    Eur Urol; 1990; 17(2):173-7. PubMed ID: 1968835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.
    Borghi L; Guerra A; Meschi T; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Mar; 55(3):1041-50. PubMed ID: 10027942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical studies of the recurrence of urolithiasis (4). Crystal formation in urine and stone recurrence].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1988 Sep; 34(9):1543-7. PubMed ID: 3213790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why does the Bonn Risk Index discriminate between calcium oxalate stone formers and healthy controls?
    Kavanagh JP; Laube N
    J Urol; 2006 Feb; 175(2):766-70. PubMed ID: 16407047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophoretic separation and characterization of urinary glycosaminoglycans and their roles in urolithiasis.
    Gohel MD; Shum DK; Tam PC
    Carbohydr Res; 2007 Jan; 342(1):79-86. PubMed ID: 17145044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitory effect of oral administration of Takusya on calcium oxalate crystallization in human whole urine].
    Honda M; Yoshimura K; Miyake O; Yoshioka T; Okuyama A; Yamaguchi S; Utsunomiya M; Koide T; Sugiyama K
    Hinyokika Kiyo; 1997 May; 43(5):333-7. PubMed ID: 9208316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Estimation of 24-h excretion of some promotors and inhibitors of crystallization and degree of urine saturation with calcium oxalate in calcium urinary calculi].
    Boruczkowska A
    Pol Arch Med Wewn; 1994 Oct; 92(4):289-98. PubMed ID: 7854956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pyridoxine supplementation on recurrent stone formers.
    Murthy MS; Farooqui S; Talwar HS; Thind SK; Nath R; Rajendran L; Bapna BC
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):434-7. PubMed ID: 7141762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
    Asokan D; Kalaiselvi P; Varalakshmi P
    Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examination of crystalluria in freshly voided urines of recurrent calcium stone formers and normal individuals using a new filter technique.
    Fan J; Chandhoke PS
    J Urol; 1999 May; 161(5):1685-8. PubMed ID: 10210440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A study of inhibitory effect of chondroitin polysulfate on stone formation of calcium oxalate].
    Fujisawa M; Arima S; Yachiku S
    Nihon Hinyokika Gakkai Zasshi; 1992 Oct; 83(10):1647-54. PubMed ID: 1434267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of calcium oxalate crystallization and urolithiasis.
    Grases F; Conte A; Genestar C; Costa-Bauzá A
    Urol Int; 1992; 48(4):409-14. PubMed ID: 1413303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.